IPO - Baird Medical Investment Holdings Ltd

Form Type: F-1/A

Filing Date: 2025-01-17

Corporate Action: Ipo

Type: Update

Accession Number: 000110465925004489

Filing Summary: Baird Medical Investment Holdings Limited is filing an amendment to its Form F-1 registration statement with the SEC, detailing an offering of up to 11,500,000 ordinary shares upon the exercise of outstanding warrants and an additional up to 34,415,562 ordinary shares for resale by certain selling securityholders. The company has filed this prospectus to comply with registration rights granted to holders of registered securities, which include shares from business combinations and private placements. This offering is conducted in conjunction with the business combination with ExcelFin Acquisition Corp., which was finalized on October 1, 2024. Prior to the Pro Rata Distribution, Betters Medical owned 76.1% of the company's issued shares, with significant stake held by Ms. Haimei Wu. Regulatory risks related to recent Chinese governmental oversight and the potential necessity for audits from PCAOB-registered firms were emphasized, indicating challenges in accessing external capital markets. Details regarding the share prices and potential returns for investors were discussed, indicating a disparity in profitability prospects based on historical pricing.

Document Link: View Document